Introducing Amvuttra:

• Your Solution for Hereditary Transthyretin-Mediated (hATTR) Amyloidosis Amvuttra, also known as vutrisiran, offers a breakthrough in the treatment of Hereditary transthyretin-mediated (hATTR) amyloidosis. It’s a biologic therapy administered via convenient subcutaneous injections, providing relief and hope to adults battling this condition.

What Is Amvuttra Used For?

• Amvuttra is a vital prescription medication designed specifically for adults diagnosed with Hereditary transthyretin-mediated (hATTR) amyloidosis. Its efficacy in managing this condition makes it a crucial component of treatment plans for eligible patients.

Getting Started with Amvuttra

• To embark on your journey with Amvuttra, obtaining a referral is the initial step. Patients seeking this innovative therapy at Infuse One must present a referral from their treating physician. The referral should include essential patient details such as name, current address, contact numbers, and insurance information.

What Information Should the Physician Provide?

• Physicians issuing referrals for Amvuttra injection therapy must include specific details to ensure a seamless process. This includes the patient’s name and date of birth, the diagnosis of Hereditary transthyretin-mediated (hATTR) amyloidosis, the physician’s name and NPI#, and comprehensive office contact information.

Documentation Matters

• Supporting clinical documentation is crucial for validating the need for Amvuttra therapy. Physicians should provide thorough documentation confirming the diagnosis of Hereditary transthyretin-mediated (hATTR) amyloidosis, ensuring a smooth approval process.

Experience Relief with Amvuttra

• Don’t let Hereditary transthyretin-mediated (hATTR) amyloidosis dictate your life. With Amvuttra, you can take proactive steps towards managing your condition effectively. Reach out to your healthcare provider today to explore if Amvuttra is right for you.